95 related articles for article (PubMed ID: 35485687)
1. Efficacy of Oral Zinc Sulfate Supplementation on Clearance of Cervical Human Papillomavirus (HPV); A Randomized Controlled Clinical Trial.
Ayatollahi H; Rajabi E; Yekta Z; Jalali Z
Asian Pac J Cancer Prev; 2022 Apr; 23(4):1285-1290. PubMed ID: 35485687
[TBL] [Abstract][Full Text] [Related]
2. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
3. Burden and genotype distribution of high-risk Human Papillomavirus infection and cervical cytology abnormalities at selected obstetrics and gynecology clinics of Addis Ababa, Ethiopia.
Ali KE; Mohammed IA; Difabachew MN; Demeke DS; Haile T; Ten Hove RJ; Kumssa TH; Woldu ZL; Haile EL; Tullu KD
BMC Cancer; 2019 Aug; 19(1):768. PubMed ID: 31382907
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program.
Alhamany Z; El Mzibri M; Kharbach A; Malihy A; Abouqal R; Jaddi H; Benomar A; Attaleb M; Lamalmi N; Cherradi N
J Infect Dev Ctries; 2010 Nov; 4(11):732-9. PubMed ID: 21252451
[TBL] [Abstract][Full Text] [Related]
5. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
[TBL] [Abstract][Full Text] [Related]
6. Age-specific 3-year cumulative risk of cervical cancer and high-grade dysplasia on biopsy in 9434 women who underwent HPV cytology cotesting.
Ge Y; Christensen PA; Luna E; Armylagos D; Xu J; Hsu JW; Zhou H; Schwartz MR; Mody DR
Cancer Cytopathol; 2019 Dec; 127(12):757-764. PubMed ID: 31589379
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus infection status of single cells isolated from cervical cytology specimens by simple manual microdissection.
Noji N; Okayama K; Oda M; Shimada A; Okodo M
J Med Virol; 2021 Aug; 93(8):5084-5094. PubMed ID: 33599297
[TBL] [Abstract][Full Text] [Related]
8. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.
Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O
Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809
[TBL] [Abstract][Full Text] [Related]
9. Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-alone or Cotesting Strategies.
Liang LA; Einzmann T; Franzen A; Schwarzer K; Schauberger G; Schriefer D; Radde K; Zeissig SR; Ikenberg H; Meijer CJLM; Kirkpatrick CJ; Kölbl H; Blettner M; Klug SJ
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):474-484. PubMed ID: 33187968
[TBL] [Abstract][Full Text] [Related]
10. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
[TBL] [Abstract][Full Text] [Related]
11. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
12. Human Papillomavirus E6/E7 oncogene transcripts as biomarkers for the early detection of cervical cancer.
Gupta SM; Warke H; Chaudhari H; Mavani P; Katke RD; Kerkar SC; Mania-Pramanik J
J Med Virol; 2022 Jul; 94(7):3368-3375. PubMed ID: 35257379
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
[TBL] [Abstract][Full Text] [Related]
14. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
15. Incidence, persistence and clearance of cervical human papillomavirus among women in Guangdong, China 2007-2018: A retrospective cohort study.
Li M; Liu T; Luo G; Sun X; Hu G; Lu Y; H Xu R; Zou H; Luo X
J Infect Public Health; 2021 Jan; 14(1):42-49. PubMed ID: 33341483
[TBL] [Abstract][Full Text] [Related]
16. Cervical Cancer Screening With Human Papillomavirus DNA and Cytology in Japan.
Sasaki Y; Iwanari O; Arakawa I; Moriya T; Mikami Y; Iihara K; Konno R
Int J Gynecol Cancer; 2017 Mar; 27(3):523-529. PubMed ID: 27997455
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus sequencing reveals its usefulness for the management of HIV-infected women at risk for developing cervical cancer.
Piyathilake CJ; Kumar R; Crowley MR; Badiga S; Burkholder GA
J Obstet Gynaecol Res; 2021 Jun; 47(6):2185-2195. PubMed ID: 33754434
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of HPV, smear and colposcopy results in patients with diabetes.
Turhan Cakir A; Sel G; Balci S; Harma M; Harma MI
Diabetes Metab Syndr; 2022 Jan; 16(1):102335. PubMed ID: 34920202
[TBL] [Abstract][Full Text] [Related]
19. Human Papillomavirus (HPV) Prevalence, Temporal Dynamics and Association with Abnormal Cervical Cytology Findings in Women from Croatia: Is there a Compounding Effect of Low-Risk/High-Risk HPV Co-Infection?
Meštrović T; Ljubin-Sternak S; Božičević I; Drenjančević D; Barać A; Kozina G; Neuberg M; Vraneš J
Clin Lab; 2020 Dec; 66(12):. PubMed ID: 33337847
[TBL] [Abstract][Full Text] [Related]
20. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
